Patent holdings for IPC class A61K 31/437

Total number of patents in this class: 10924

10-year publication summary

710
763
795
797
763
787
726
814
822
562
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
4748
170
Incyte Corporation
1066
140
F. Hoffmann-La Roche AG
7815
126
Genentech, Inc.
4115
122
Takeda Pharmaceutical Company Limited
2712
120
Boehringer Ingelheim International GmbH
4483
106
Janssen Pharmaceutica N.V.
3161
104
Merck Sharp & Dohme LLC
3736
104
Novartis AG
10178
103
Gilead Sciences, Inc.
2231
99
Merck Patent GmbH
5735
85
Hoffmann-La Roche Inc.
3815
76
The Regents of the University of California
20802
74
Pfizer Inc.
3404
67
Bayer Pharma AG
1010
66
Abbvie Inc.
1822
64
Dana-Farber Cancer Institute, Inc.
2668
64
Plexxikon Inc.
146
59
Taisho Pharmaceutical Co., Ltd.
850
59
AstraZeneca AB
2824
55
Other owners 9061